The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37

Current Opinion in Virology 2026

View at publisher
Authors: Elvira Ianni, Daniela Stranges, Derek T O’Hagan
DOI: 10.1016/j.coviro.2026.101568
Cited by: 1
References: 40

Fields of Study & Subjects

vaccines and immunoinformatics approaches Peripheral Neuropathies and Disorders Immunotherapy and Immune Responses

Publication details

Journal / source
Current Opinion in Virology
Publisher
Elsevier BV
Volume
77
Pages
101568–101568
Publication date
10 July 2026
Language
EN